Cargando…
Small Molecule SARM1 Inhibitors Recapitulate the SARM1(−/−) Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
Axonal degeneration is responsible for disease progression and accumulation of disability in many neurodegenerative conditions. The axonal degenerative process can generate a metastable pool of damaged axons that remain structurally and functionally viable but fated to degenerate in the absence of e...
Autores principales: | Hughes, Robert O., Bosanac, Todd, Mao, Xianrong, Engber, Thomas M., DiAntonio, Aaron, Milbrandt, Jeffrey, Devraj, Rajesh, Krauss, Raul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8179325/ https://www.ncbi.nlm.nih.gov/pubmed/33406435 http://dx.doi.org/10.1016/j.celrep.2020.108588 |
Ejemplares similares
-
NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion
por: Sasaki, Yo, et al.
Publicado: (2016) -
Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
por: Bosanac, Todd, et al.
Publicado: (2021) -
SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
por: Ko, Kwang Woo, et al.
Publicado: (2020) -
Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
por: Geisler, Stefanie, et al.
Publicado: (2019) -
Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
por: Bloom, A. Joseph, et al.
Publicado: (2022)